To functionally validate whether CTLA-4negative anti-CD123 CAR T cells are responsible for sustained anti-leukemia effects and subsequently improved survival in AML-bearing mice, CTLA-4negative or CTLA-4positive CAR T cells were transferred into leukemia-bearing mice. This evidence concerns the gene IL3RA and leukemia.